Literature DB >> 14599554

Involvement of advanced lipooxidation end products (ALEs) and protein oxidation in the apoptotic actions of nitric oxide in insulin secreting RINm5F cells.

Gladys M Cahuana1, Juan R Tejedo, Juan Jiménez, Remedios Ramírez, Francisco Sobrino, Francisco J Bedoya.   

Abstract

We have explored the impact of nitric oxide (NO) exposure on oxidation damage of lipids, and proteins, and the contribution of this type of damage to the activation of the apoptotic program in insulin secreting RINm5F cells. Exposure of cells to NO donors and to interleukin-1 beta (IL-1beta) led to generation of lipooxidation products such as malondialdehyde (MDA) and 4-hydroxynonenal (4-HNE). Addition of superoxide dismutase (SOD) and catalase (Cat) to cells decreased by 50% MDA and 4-HNE production induced by IL-1beta. Over-expression of Mn-SOD in cells conferred a remarkable decrease (75%) in IL-1beta-induced lipid peroxidation. These data suggest that peroxynitrite (ONOO(-)) mediates peroxidative damage to lipids in this cell system. Inhibitors of advanced lipooxidation end products (ALEs) formation such as aminoguanidine (AG) and pyridoxamine (PM) prevented partially apoptotic events triggered by NO such as DNA fragmentation, caspase-3 activation and cytochrome c release from mitochondria. These findings indicate that ALEs are involved in NO-induced apoptosis. In fact, NO-induced carbonylation of PARP protein preceded its apoptotic degradation and inhibitors of ALEs formation prevented both events. We thus propose that carbonylation of proteins is instrumental in linking NO-dependent lipid oxidation and apoptosis in this cell system.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14599554     DOI: 10.1016/j.bcp.2003.07.004

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  8 in total

1.  SR-135, a peroxynitrite decomposing catalyst, enhances β-cell function and survival in B6D2F1 mice fed a high fat diet.

Authors:  Michael Johns; Robert Fyalka; Jennifer A Shea; William L Neumann; Smita Rausaria; Eliwaza Naomi Msengi; Maryam Imani-Nejad; Harry Zollars; Timothy McPherson; Joseph Schober; Joshua Wooten; Guim Kwon
Journal:  Arch Biochem Biophys       Date:  2015-04-29       Impact factor: 4.013

2.  Rosmarinic acid modulates the antioxidant status and protects pancreatic tissues from glucolipotoxicity mediated oxidative stress in high-fat diet: streptozotocin-induced diabetic rats.

Authors:  Jayanthy Govindaraj; Subramanian Sorimuthu Pillai
Journal:  Mol Cell Biochem       Date:  2015-03-04       Impact factor: 3.396

Review 3.  Approaches to prevention of cardiovascular complications and events in diabetes mellitus.

Authors:  Sergio Coccheri
Journal:  Drugs       Date:  2007       Impact factor: 9.546

4.  An angiotensin II type-I receptor blocker, olmesartan medoxomil, attenuates lipid peroxidation in renal injury induced by subtotal nephrectomy.

Authors:  Toshiyuki Takahashi; Tsuneo Konta; Satoshi Takasaki; Kazunobu Ichikawa; Yasuchika Takeishi; Isao Kubota
Journal:  Clin Exp Nephrol       Date:  2007-09-28       Impact factor: 2.801

Review 5.  Advanced lipid peroxidation end products in oxidative damage to proteins. Potential role in diseases and therapeutic prospects for the inhibitors.

Authors:  A Negre-Salvayre; C Coatrieux; C Ingueneau; R Salvayre
Journal:  Br J Pharmacol       Date:  2007-07-23       Impact factor: 8.739

Review 6.  Cardiovascular consequences when nitric oxide and lipid signaling converge.

Authors:  Volker Rudolph; Bruce A Freeman
Journal:  Circ Res       Date:  2009-09-11       Impact factor: 17.367

Review 7.  Protein carbonylation, cellular dysfunction, and disease progression.

Authors:  Isabella Dalle-Donne; Giancarlo Aldini; Marina Carini; Roberto Colombo; Ranieri Rossi; Aldo Milzani
Journal:  J Cell Mol Med       Date:  2006 Apr-Jun       Impact factor: 5.310

Review 8.  Lipoxidation in cardiovascular diseases.

Authors:  Erica Gianazza; Maura Brioschi; Alma Martinez Fernandez; Cristina Banfi
Journal:  Redox Biol       Date:  2019-02-25       Impact factor: 11.799

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.